Impact of COVID-19 on patients with congenital heart disease

Cardiol Young. 2021 Jan;31(1):163-165. doi: 10.1017/S1047951120004345. Epub 2020 Dec 14.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • COVID-19 / complications*
  • COVID-19 / mortality
  • COVID-19 / therapy
  • Cardiotonic Agents / therapeutic use
  • Child
  • Extracorporeal Membrane Oxygenation
  • Heart Defects, Congenital / complications*
  • Heart Defects, Congenital / therapy
  • Humans
  • Noninvasive Ventilation
  • Positive-Pressure Respiration
  • SARS-CoV-2

Substances

  • Cardiotonic Agents